Skip to Main content
Skip to Navigation
Toggle navigation
Sign in
Sign in
Sign in with ORCID
se connecter avec Fédération
Create account
Forgot your password?
Have you forgotten your login?
fr
en
Centre Eugène Marquis
Home
Home
Collection HAL FNCLCC
Browse
Document list
Last articles
By year
By authors in the Centre
By document type
Simple search
Centre site
Home
Home
Last submissions
Valentin Oreiller, Vincent Andrearczyk, Mario Jreige, Sarah Boughdad, Hesham Elhalawani, et al.. Head and neck tumor segmentation in PET/CT: The HECKTOR challenge. Medical Image Analysis, Elsevier, 2022, 77, pp.102336. ⟨10.1016/j.media.2021.102336⟩. ⟨hal-03711820⟩
Julien Bellec, Louis Rigal, Aurélien Hervouin, Raphaël Martins, Mathieu Lederlin, et al.. Cardiac radioablation for ventricular tachycardia: Which approach for incorporating cardiorespiratory motions into the planning target volume?. Physica Medica, Elsevier, 2022, 95, pp.16-24. ⟨10.1016/j.ejmp.2022.01.004⟩. ⟨hal-03554463⟩
Aitor Almanza, Katarzyna Mnich, Arnaud Blomme, Claire M. Robinson, Giovanny Rodriguez-Blanco, et al.. Regulated IRE1 alpha-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancer. Nature Communications, Nature Publishing Group, 2022, 13 (1), pp.2493. ⟨10.1038/s41467-022-30159-0⟩. ⟨hal-03689648⟩
Charly Gutierrez, Xavier Pinson, Kathleen Jarnouen, Marine Charpentier, Raphaël Pineau, et al.. Characterization of the Peri-Membrane Fluorescence Phenomenon Allowing the Detection of Urothelial Tumor Cells in Urine. Cancers, MDPI, 2022, 14 (9), pp.2171. ⟨10.3390/cancers14092171⟩. ⟨hal-03689487⟩
Sophie Martin, Christopher Heslan, Guillaume Jégou, Leif A Eriksson, Matthieu Le Gallo, et al.. SARS-CoV-2 integral membrane proteins shape the serological responses of COVID-19 patients. iScience, Elsevier, 2021, 24 (10), pp.103185. ⟨10.1016/j.isci.2021.103185⟩. ⟨hal-03370005⟩
Cindy Neuzillet, Corinne Emery, Clément Teissier, Stéphane Bouée, Astrid Lièvre. Patient healthcare trajectories of intrahepatic cholangiocarcinoma in France: A nationwide retrospective analysis. The Lancet Regional Health - Europe, Elsevier, 2022, 15, pp.100324. ⟨10.1016/j.lanepe.2022.100324⟩. ⟨hal-03595565⟩
Kosala N Amarasinghe, Diana Pelizzari-Raymundo, Antonio Carlesso, Eric Chevet, Leif A Eriksson, et al.. Sensor dimer disruption as a new mode of action to block the IRE1-mediated unfolded protein response. Computational and Structural Biotechnology Journal, Elsevier, 2022, 20, pp.1584-1592. ⟨10.1016/j.csbj.2022.03.029⟩. ⟨hal-03660238⟩
Sophie Martin, Gwénaële Jégou, Aurore Nicolas, Matthieu Le Gallo, Éric Chevet, et al.. A cell-based system combined with flow cytometry to evaluate antibody responses against SARS-CoV-2 transmembrane proteins in patients with COVID-19. STAR Protocols, Elsevier, 2022, 3 (1), pp.101229. ⟨10.1016/j.xpro.2022.101229⟩. ⟨hal-03632340⟩
Myriam Le Roch, Damien Afonso, Egor Chirkin, Xavier Guillory, François-Hugues Porée. Structure simplification of the Securinine skeleton reveals the importance of BCD ring system for the cytotoxic activity on HCT116 and HL60 cell lines. Bioorganic and Medicinal Chemistry, Elsevier, 2022, 58, pp.116658. ⟨10.1016/j.bmc.2022.116658⟩. ⟨hal-03683055⟩
David Luque Paz, Stephane Jouneau, Pierre Tattevin, Charles Ricordel. Pneumocystis in metastatic lung cancer, a pragmatic approach in support of prophylaxis. BMJ Case Reports, BMJ Publishing Group, 2021, 14 (6), pp.e232895. ⟨10.1136/bcr-2019-232895⟩. ⟨hal-03372959⟩
Charles Ricordel. Les protéines ING2 et ING3 : identification de nouvelles fonctions et implication en cancérologie. Médecine humaine et pathologie. Université Rennes 1, 2022. Français. ⟨NNT : 2022REN1B002⟩. ⟨tel-03667155⟩
Laura Mary, Delphine Leclerc, David Gilot, Marc-Antoine Belaud-Rotureau, Sylvie Jaillard. The TALE never ends: a comprehensive overview of the role of PBX1, a TALE transcription factor, in human developmental defects. Human Mutation, Wiley, 2022, ⟨10.1002/humu.24388⟩. ⟨hal-03660222⟩
Antoine Girard, Pierre-Jean Le Reste, Alice Metais, Nibras Chaboub, Anne Devillers, et al.. Additive Value of Dynamic FDOPA PET/CT for Glioma Grading. Frontiers in Medicine, Frontiers media, 2021, 8, pp.705996. ⟨10.3389/fmed.2021.705996⟩. ⟨hal-03329582⟩
Emna Mahfoudhi, Charles Ricordel, Gwendoline Lecuyer, Cécile Mouric, Hervé Lena, et al.. Preclinical Models for Acquired Resistance to Third-Generation EGFR Inhibitors in NSCLC: Functional Studies and Drug Combinations Used to Overcome Resistance. Frontiers in Oncology, Frontiers, 2022, 12, pp.853501. ⟨10.3389/fonc.2022.853501⟩. ⟨hal-03660230⟩
Nicolas Lepareur. Cold Kit Labeling: The Future of (68)Ga Radiopharmaceuticals?. Frontiers in Medicine, Frontiers media, 2022, 9, pp.812050. ⟨10.3389/fmed.2022.812050⟩. ⟨hal-03594485⟩
Pavla Bouchalova, Lucia Sommerova, David Potesil, Andrea Martisova, Petr Lapcik, et al.. Characterization of the AGR2 interactome uncovers new players of Protein Disulfide Isomerase network in cancer cells. Molecular and Cellular Proteomics, American Society for Biochemistry and Molecular Biology, 2022, 21 (2), pp.100188. ⟨10.1016/j.mcpro.2021.100188⟩. ⟨hal-03514541⟩
Jules Tianyu Zhang-yin, Antoine Girard, Marc Bertaux. What Does PET Imaging Bring to Neuro-Oncology in 2022? A Review. Cancers, MDPI, 2022, 14 (4), pp.879. ⟨10.3390/cancers14040879⟩. ⟨hal-03660720⟩
Astrid Lièvre. Anti-PD-1 for pretreated advanced anal carcinoma: which patients will benefit?. The Lancet Gastroenterology and Hepatology, Elsevier, 2022, 7 (5), pp.384-386. ⟨10.1016/S2468-1253(22)00002-4⟩. ⟨hal-03594523⟩
Helena Dragic, Audrey Barthelaix, Cédric Duret, Simon Le Goupil, Hadrien Laprade, et al.. The hexosamine pathway and coat complex II promote malignant adaptation to nutrient scarcity. Life Science Alliance, Life Science Alliance LLC, 2022, 5 (7), pp.e202101334. ⟨10.26508/lsa.202101334⟩. ⟨hal-03660129⟩
Elise Vene, Kathleen Jarnouen, Catherine Ribault, Manuel Vlach, yann Verres, et al.. Circumsporozoite Protein of Plasmodium berghei- and George Baker Virus A-Derived Peptides Trigger Efficient Cell Internalization of Bioconjugates and Functionalized Poly(ethylene glycol)-b-poly(benzyl malate)-Based Nanoparticles in Human Hepatoma Cells. Pharmaceutics, 2022, 14 (4), pp.804. ⟨10.3390/pharmaceutics14040804⟩. ⟨hal-03657832⟩
Number of fulltext
408
Number of reference
555
Submissions evolution
Submissions distribution by document type